Work

POSTER: ABCL-837 The CNS-IPI Score Is Predictive of the Risk of Severe ICANS After Axicabtagene Ciloleucel Treatment in Patients With Large B-Cell Lymphoma

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)01041-9

Authors: Sergi Camarillas, Samantha Feijoo, Corrado Benevolo, Anna Aguilera, Victor Navarro, Maria Landwehr, Andreu Vilaseca, Helena Ariño, Cecilia Carpio, Mario Sánchez-Salinas, Pau Abrisqueta, Francesc Bosch, Pere Barba, Gloria Iacoboni

Institutions: Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Centre d'Esclerosi Múltiple de Catalunya

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413809685

FWCI:

Cites:

Cited by:

Related to: 10